Myelodysplastic Syndromes: Guidance on the Optimal Management of Older Adult Patients

Interact with an expert during a 1-hour, CME/CE/CPE-certified live meeting focused on optimal strategies for the management of myelodysplastic syndromes (MDS) in older adult patients. Register today!

Agenda

  • Understanding the Older Adult Patient Population
  • Features of MDS That Predispose Older Patients to Risk
  • Navigating Clinical Challenges With Older Patients With MDS
  • Expert Guidance to Optimize Outcomes for Older Patients

Faculty

Faculty
Rami S. Komrokji, MD

Senior Member, Vice Chair
Malignant Hematology
Section Head
Leukemia and MDS
H. Lee Moffitt Cancer Center & Research Institute
Professor
Department of Oncologic Sciences
University of South Florida
Tampa, Florida

Faculty
Jamile Shammo, MD, FASCP, FACP

Professor of Medicine and Pathology
Division of Hematology, Oncology, and Stem Cell Transplant
Director, MDS/MPN/Aplastic Anemia Program 
Rush University Medical Center
Chicago, Illinois

Target Audience
This educational program is intended for US-based hematologists/oncologists and medical oncologists treating older adult patients with MDS at academic and community treatment centers.

Learning Objectives

  • Use tumor and patient characteristics, informed by patient preference, to select optimal treatment for older adult patients with MDS
  • Foster collaborative discussions between older patients/caregivers and HCPs on guidelines and recent clinical evidence to guide personalized treatment planning for older patients with MDS
  • Recognize and manage adverse events associated with approved treatment regimens for MDS, considering existing comorbidities of older adult patients with MDS
  • Implement resources to guide HCPs, and engage older adult patients/caregivers in shared decision-making to improve MDS outcomes

 

Accreditation

In support of improving patient care, Rush University Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity is being presented without bias and with commercial support.

Credit Designation Statements

For Medicine:
Rush University Medical Center designates this live internet activity for a maximum of one (1) AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

For Nursing:
Rush University Medical Center designates this live internet activity for a maximum of one (1) nursing contact hour.

For Pharmacy:
Rush University Medical Center designates this knowledge-based live internet activity for a maximum of one (1) contact hour for pharmacists.

Disclosure Policy:
As a provider of continuing education, Rush University Medical Center asks everyone who has the ability to control or influence the content of an educational activity to disclose information about all of their financial relationships with ineligible companies within the prior 24 months.  There is no minimum financial threshold; individuals must disclose all financial relationships, regardless of the amount, with ineligible companies.  Individuals must disclose regardless of their view of the relevance of the relationship to the education.  Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.

FDA statement:
Unapproved Uses of Drugs/Devices: In accordance with requirements of the FDA, the audience is advised that information presented in this continuing medical education activity may contain references to unlabeled or unapproved uses of drugs or devices.  Please refer to the FDA approved package insert for each drug/device for full prescribing/utilization information.